60
Participants
Start Date
October 31, 2025
Primary Completion Date
May 31, 2028
Study Completion Date
May 31, 2028
Dual Antiplatelet (DAPT) Therapy
aspirin 100 mg daily plus clopidogrel 75 mg daily or ticagrelor 90 mg per dose, twice daily for 30 consecutive days
Rivaroxaban
Rivaroxaban (2.5 mg twice daily) plus aspirin 100 mg daily plus clopidogrel 75 mg daily for 30 days
Affiliated Hospital of Jiaxing University
OTHER
The Second Affiliated Hospital of Jiaxing University
OTHER
Wenzhou People's Hospital
OTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
OTHER